바이오테크 보도자료
-
- BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
- BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced financial results and corporate updates from the fourth quarter and full year 2024. “Our fou...
- 03월 07일 13:30
-
- Novotech Releases Hepatitis B Global Clinical Trial Landscape Report 2025
- Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released its latest disease report: Hepatitis B - Global Cli...
- 03월 07일 11:45
-
- Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products
- Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future release of their Evercode™ single cell chromatin products. This comes on the heels of Parse invalida...
- 03월 06일 11:30
-
- Arthur D. Little Study Establishes Precise Impact of AI on Development and Engineering and Outlines Concrete Actions to Drive Success
- Harnessing AI will transform development and engineering functions - but success requires organizations to reshape themselves. That is one of key findings of a major Arthur D. Little (ADL) report, which highlights how AI can contribute to 25% grow...
- 03월 05일 09:29
-
- Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
- Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX ) and Takeda (TSE:4502/NYSE:TAK ) today announced positive topline results for the Phase 3 VERIFY study, in which phlebotomy-dependent patients with polycythemia vera (PV) were randomized...
- 03월 04일 10:49
-
- AAD 2025: Galderma to Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leadership and Strong Momentum
- Galderma will present updates from across its broad dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 7-11, 2025 in Orlando, Florida. The company will present 22 e-posters - including t...
- 03월 03일 16:20
-
- Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema
- Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced the initiation of the ALPHA-ORBIT Phase 3 clinical trial of navenibart in peo...
- 03월 03일 12:00
-
- SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
- Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal court order (the “Order”) from the Privy Council foll...
- 03월 03일 10:40
-
- The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity
- The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in cosmetics to deliver significant skin care long...
- 02월 28일 11:25
-
- Gradiant and GF Piping Systems Partner to Drive Innovation and Sustainability in Industrial Water
- Gradiant , a global leader in advanced water and wastewater treatment, today announced a strategic partnership with GF Piping Systems, a leading flow solutions provider. This collaboration solidifies Gradiant’s capabilities to deliver high-perform...
- 02월 25일 10:25
-
- ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)
- Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. (“PharmaEssentia”) and AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in AOP Health’s favor....
- 02월 23일 13:20
전시회
